{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T14:05:21Z","timestamp":1790258721939,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier","isbn-type":[{"value":"9780443430862","type":"print"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/bs.acr.2026.01.002","type":"book-chapter","created":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T12:18:37Z","timestamp":1769775517000},"page":"235-257","source":"Crossref","is-referenced-by-count":3,"title":["Challenges in translating nanotechnology from research to clinical practice"],"prefix":"10.1016","author":[{"family":"Yash","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhavesh","family":"Dharmani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajwinder","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diksha","family":"Choudhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohit","family":"Bhatia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankush","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun Kumar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/bs.acr.2026.01.002_bib1","series-title":"Nanocarriers\u00a0in\u00a0neurodegenerative\u00a0disorders","first-page":"84","article-title":"Regulations and ethics of nanomedicine and public acceptance","author":"Abdel-Monaem","year":"2025"},{"issue":"15","key":"10.1016\/bs.acr.2026.01.002_bib2","doi-asserted-by":"crossref","first-page":"5905","DOI":"10.3390\/molecules28155905","article-title":"Exploring nanocarriers as treatment modalities for skin cancer","volume":"28","author":"Adnan","year":"2023","journal-title":"Molecules (Basel, Switzerland)"},{"issue":"6","key":"10.1016\/bs.acr.2026.01.002_bib3","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.3390\/pharmaceutics15061630","article-title":"Biomarkers as biomedical bioindicators: Approaches and techniques for the detection, analysis, and validation of novel biomarkers of diseases","volume":"15","author":"Ahmad","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/bs.acr.2026.01.002_bib4","unstructured":"Ahsun, A. (2024). Navigating the Regulatory Landscape of Nanoparticle Technology in Healthcare."},{"issue":"2","key":"10.1016\/bs.acr.2026.01.002_bib5","first-page":"10","article-title":"Nanopharmaceuticals: Patenting issues and FDA regulatory challenges","volume":"5","author":"Bawa","year":"2008","journal-title":"The SciTech Lawyer"},{"issue":"9","key":"10.1016\/bs.acr.2026.01.002_bib6","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1007\/s13346-024-01646-2","article-title":"Toward an international standardisation roadmap for nanomedicine","volume":"14","author":"Caputo","year":"2024","journal-title":"Drug Delivery and Translational Research"},{"issue":"9","key":"10.1016\/bs.acr.2026.01.002_bib7","doi-asserted-by":"crossref","first-page":"8139","DOI":"10.1021\/acsnano.6b05610","article-title":"Patients, here comes more nanotechnology","volume":"10","author":"Chan","year":"2016","journal-title":"ACS Nano"},{"issue":"3","key":"10.1016\/bs.acr.2026.01.002_bib8","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1111\/bcp.15003","article-title":"Learning from remote decentralised clinical trial experiences: a qualitative analysis of interviews with trial personnel, patient representatives and other stakeholders","volume":"88","author":"Coyle","year":"2022","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1016\/bs.acr.2026.01.002_bib9","unstructured":"Di Trapani, G.\u00a0(2021). Evaluation and planning study of a smart nanomedicine platform able to fight cancer relapse with remote activation. Politecnico di Torino."},{"key":"10.1016\/bs.acr.2026.01.002_bib10","first-page":"1","article-title":"Current hurdles to the translation of nanomedicines from bench to the clinic","author":"\u0110or\u0111evi\u0107","year":"2022","journal-title":"Drug Delivery and Translational Research"},{"issue":"12","key":"10.1016\/bs.acr.2026.01.002_bib11","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1093\/ajhp\/zxab048","article-title":"Tackling the challenges of nanomedicines: Are we ready?","volume":"78","author":"Hertig","year":"2021","journal-title":"American Journal of Health-System Pharmacy"},{"issue":"2","key":"10.1016\/bs.acr.2026.01.002_bib12","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1039\/C8NH00233A","article-title":"Artificial intelligence in nanomedicine","volume":"4","author":"Ho","year":"2019","journal-title":"Nanoscale Horizons"},{"key":"10.1016\/bs.acr.2026.01.002_bib13","series-title":"Nanomedicine. Nanotechnology in the life sciences","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/978-3-031-72467-1_2","article-title":"Navigating safety and toxicity challenges in nanomedicine: Strategies, assessment, and mitigation","author":"Kumar","year":"2024"},{"issue":"5","key":"10.1016\/bs.acr.2026.01.002_bib14","doi-asserted-by":"crossref","first-page":"204","DOI":"10.5694\/mja15.00681","article-title":"Cancer nanomedicine: Challenges and opportunities","volume":"203","author":"Kuncic","year":"2015","journal-title":"Medical Journal of Australia"},{"issue":"4","key":"10.1016\/bs.acr.2026.01.002_bib15","doi-asserted-by":"crossref","first-page":"1800128","DOI":"10.1002\/adtp.201800128","article-title":"Advancing cancer immunotherapies with nanotechnology","volume":"2","author":"Lou","year":"2019","journal-title":"Advanced Therapeutics"},{"key":"10.1016\/bs.acr.2026.01.002_bib16","unstructured":"Lousa, I.R.\u00a0(2024). Pharmaceutical regulation of nanomedicines: Principles and challenges.\u00a0Universidade de Lisboa (Portugal)."},{"key":"10.1016\/bs.acr.2026.01.002_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.120910","article-title":"Reappraisal of anticancer nanomedicine design criteria in three types of preclinical cancer models for better clinical translation","volume":"275","author":"Luan","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/bs.acr.2026.01.002_bib18","first-page":"193","article-title":"Skin cancer treatment with emphasis on nanotechnology","author":"Murugan","year":"2021","journal-title":"Skin Cancer: Pathogenesis and Diagnosis"},{"issue":"6","key":"10.1016\/bs.acr.2026.01.002_bib19","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1208\/s12249-014-0177-9","article-title":"Nanomedicine scale-up technologies: Feasibilities and challenges","volume":"15","author":"Paliwal","year":"2014","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/bs.acr.2026.01.002_bib20","series-title":"Emerging technologies for nanoparticle manufacturing","first-page":"511","article-title":"Nanomedicine scale-up technologies: Feasibilities and challenges","author":"Patel","year":"2021"},{"key":"10.1016\/bs.acr.2026.01.002_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2023.104394","article-title":"Nanomedicine: A pragmatic approach for tackling melanoma skin cancer","volume":"83","author":"Prajapat","year":"2023","journal-title":"Journal of Drug Delivery Science and Technology"},{"key":"10.1016\/bs.acr.2026.01.002_bib22","doi-asserted-by":"crossref","DOI":"10.1021\/acsnano.4c13513","article-title":"Voices of nanomedicine: Blueprint guidelines for collaboration in addressing global unmet medical needs","author":"Prasad","year":"2025","journal-title":"ACS nano"},{"key":"10.1016\/bs.acr.2026.01.002_bib23","doi-asserted-by":"crossref","first-page":"1212949","DOI":"10.3389\/fmed.2023.1212949","article-title":"Classification system for nanotechnology-enabled health products with both scientific and regulatory application","volume":"10","author":"Rodr\u00edguez-G\u00f3mez","year":"2023","journal-title":"Frontiers in Medicine"},{"issue":"4","key":"10.1016\/bs.acr.2026.01.002_bib24","first-page":"11931","article-title":"How to face skin cancer with nanomaterials: A review","volume":"11","author":"Sabir","year":"2021","journal-title":"Biointerface Research in Applied Chemistry"},{"key":"10.1016\/bs.acr.2026.01.002_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114194","article-title":"Artificial intelligence to bring nanomedicine to life","volume":"184","author":"Serov","year":"2022","journal-title":"Advanced Drug Delivery Reviews"},{"issue":"1","key":"10.1016\/bs.acr.2026.01.002_bib26","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1021\/acsnano.2c09249","article-title":"The issue of reliability and repeatability of analytical measurement in industrial and academic nanomedicine","volume":"17","author":"Sharifi","year":"2022","journal-title":"ACS nano"},{"key":"10.1016\/bs.acr.2026.01.002_bib27","article-title":"Regulatory considerations of material used for medical devices and combination products in different countries: A review","author":"Singh","year":"2023","journal-title":"Materials Today: Proceedings"},{"key":"10.1016\/bs.acr.2026.01.002_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.actbio.2024.04.010","article-title":"Regulatory insights into nanomedicine and gene vaccine innovation: Safety assessment, challenges, and regulatory perspectives","author":"Souto","year":"2024","journal-title":"Acta Biomaterialia"},{"key":"10.1016\/bs.acr.2026.01.002_bib29","series-title":"Nanoformulation\u00a0strategies\u00a0for\u00a0cancer\u00a0treatment","first-page":"341","article-title":"Good laboratory practice\u00a0and current good manufacturing practice requirements in the development of cancer nanomedicines","author":"Taleuzzaman","year":"2021"},{"issue":"1","key":"10.1016\/bs.acr.2026.01.002_bib30","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s40005-022-00607-6","article-title":"Nanomedicine-based commercial formulations: Current developments and future prospects","volume":"53","author":"Thapa","year":"2023","journal-title":"Journal of Pharmaceutical Investigation"},{"issue":"1","key":"10.1016\/bs.acr.2026.01.002_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/17425247.2017.1262346","article-title":"Cancer nanomedicines: oversold or underappreciated?","volume":"14","author":"van der Meel","year":"2017","journal-title":"Expert Opinion on Drug Delivery"},{"key":"10.1016\/bs.acr.2026.01.002_bib32","article-title":"Grand challenges in nanomedicine","volume":"106","author":"Wu","year":"2020","journal-title":"Materials Science and Engineering: C"},{"issue":"2","key":"10.1016\/bs.acr.2026.01.002_bib33","doi-asserted-by":"crossref","first-page":"57","DOI":"10.15212\/bioi-2021-0016","article-title":"Challenges and opportunities of nanomedicines in clinical translation","volume":"2","author":"Zheng","year":"2021","journal-title":"Bio Integration"}],"container-title":["Advances in Cancer Research","Innovative Nanotechnology: Transforming Skin Cancer Diagnosis and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0065230X26000023?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0065230X26000023?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T20:13:27Z","timestamp":1777493607000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0065230X26000023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9780443430862"],"references-count":33,"URL":"https:\/\/doi.org\/10.1016\/bs.acr.2026.01.002","relation":{},"ISSN":["0065-230X"],"issn-type":[{"value":"0065-230X","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]}}}